YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017

This table browses all dspace content
Issue Date	Title	Journal Title
2025	KRASG12D selective VHL-PROTAC with sparing KRASWT and other KRAS mutants	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2025	Predictive models for posttransplant diabetes mellitus in kidney transplant recipients using machine learning and deep learning approach: a nationwide cohort study from South Korea	KIDNEY RESEARCH AND CLINICAL PRACTICE
2025	Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study	TARGETED ONCOLOGY
2025	Lazertinib Versus Osimertinib in Previously Untreated EGFR-Mutant Advanced NSCLC: A Randomized, Double-Blind, Exploratory Analysis From MARIPOSA	JOURNAL OF THORACIC ONCOLOGY
2025	A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC	JOURNAL OF THORACIC ONCOLOGY
2025	Pharmacokinetics and bioavailability of pembrolizumab with berahyaluronidase alfa for subcutaneous administration in participants with advanced or metastatic solid tumors: The phase 1 study 3475A-C18	EUROPEAN JOURNAL OF CANCER
2025	Proliferation of Tumor-Related Regulatory T Cells in Circulation Dictates Efficacy of Chemoimmunotherapy in Triple-Negative Breast Cancer	CLINICAL CANCER RESEARCH
2025	Comprehensive approaches to diabetes in the elderly: adapting to evolving trends	KOREAN JOURNAL OF INTERNAL MEDICINE
2025	Sarcopenia and MASLD: novel insights and the future	NATURE REVIEWS ENDOCRINOLOGY
2025	Efficacy and Safety of Fimasartan, Atorvastatin, and Ezetimibe Combination Therapy in Patients With Hypertension and Dyslipidemia: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical Trial	CLINICAL THERAPEUTICS
2025	Left Ventricular and Atrial Function in Patients With Isolated Mitral Annular Calcification	JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
2025	Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study)	DIABETES OBESITY & METABOLISM
2025	A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy	NEW ENGLAND JOURNAL OF MEDICINE
2025	Triglyceride-glucose index and risk of renal function decline and death-censored renal allograft loss in kidney transplant recipients	KIDNEY RESEARCH AND CLINICAL PRACTICE
2025	Emergence of aldosterone synthase inhibitors for treatment of difficult to treat hypertension	HYPERTENSION RESEARCH
2025	Entropy and Human Aging	AGING CELL
2025	Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents	NEW ENGLAND JOURNAL OF MEDICINE
2025	Metabolic Surgery for Obese Type 2 Diabetes: Korean Multicenter Cohort Study	OBESITY SURGERY
2025	Dynamic changes of natural killer cell immunophenotypes and receptors according to the mortality in the intra-abdominal murine sepsis model	INTENSIVE CARE MEDICINE EXPERIMENTAL
2025	Investigation of the Impact of Body Mass Index in the 20s on Chronic Metabolic Diseases and Their Progression Rate After the Age of 65 Years	JOURNAL OF KOREAN MEDICAL SCIENCE